Forma Therapeutics (FMTX) Downgraded by Zacks Investment Research to Sell

Forma Therapeutics} stock has undergone multiple analysts rating changes in the recent past.  Forma Therapeutics Downgraded by Zacks Investment Research on 10/11/2021. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Hold.

View More Forma Therapeutics (FMTX) Downgraded by Zacks Investment Research to Sell